MITOXANTRONE, 5-FU, AND LEUCOVORIN IN BREAST-CANCER

被引：2
|
作者：
SWAIN, SM
HONIG, SF
机构：
[1] Lombardi Cancer Research Center, Department of Medicine, Division of Medical Oncology, Washington, District of Columbia
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1994年 / 22卷 / 06期
关键词：
MITOXANTRONE; 5-FLUOROURACIL; LEUCOVORIN; CHEMOTHERAPY OF BREAST CANCER;
D O I：
10.1002/mpo.2950220603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Eighteen patients (17 evaluable for response) with metastatic breast cancer were treated with mitoxantrone 10 mg/m(2) day 1, followed by 5-fluorouracil 375 mg/m(2) day 1-5, and high-dose leucovorin 500 mg/m(2) day 1-5 given every 28 days. There was one complete and four partial responses for an objective response rate of 30% and 41% stable disease. The major toxicities were hematologic and gastrointestinal. This regimen has activity in metastatic breast cancer comparable to conventional and/or standard chemotherapy regimens for advanced disease. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码：370 / 374
页数：5
相关论文
共 50 条
  • [21] MITOXANTRONE, 5-FLUOROURACIL AND LEVO-LEUCOVORIN AS SALVAGE TREATMENT IN ADVANCED BREAST-CANCER PATIENTS
    MAMMOLITI, S
    MERLINI, L
    CAROTI, C
    GALLO, L
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (02) : 248 - 249
  • [22] PHASE-II STUDY OF WEEKLY MITOXANTRONE, 5-FLUOROURACIL, AND LEUCOVORIN IN METASTATIC BREAST-CANCER
    REPETTO, L
    MIGLIETTA, L
    GARDIN, G
    LANFRANCO, C
    NASO, C
    MERLINI, L
    GIUDICI, S
    VENTURINO, A
    CAMPORA, E
    TESTORE, F
    ROSSO, R
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (02) : 133 - 137
  • [23] 5-FLUOROURACIL WITH LEUCOVORIN IN BREAST-CANCER
    LOPRINZI, CL
    CANCER, 1989, 63 (06) : 1045 - 1047
  • [24] A RANDOMIZED COMPARATIVE TRIAL OF MITOXANTRONE METHOTREXATE MITOMYCIN-C (MMM) AND CYCLOPHOSPHAMIDE METHOTREXATE 5-FU (CMF) IN THE TREATMENT OF ADVANCED BREAST-CANCER
    JODRELL, DI
    SMITH, IE
    MANSI, JL
    PEARSON, MC
    WALSH, G
    ASHLEY, S
    SINNETT, HD
    MCKINNA, JA
    BRITISH JOURNAL OF CANCER, 1991, 63 (05) : 794 - 798
  • [25] Continuous infusion (CI) of 5 fluorouracil (5-FU) and oral leucovorin (LCV) in the treatment of metastatic breast cancer (MBC)
    Lyass, O
    Temper, M
    Brufman, G
    Gabizon, A
    Hubert, A
    Peretz, T
    Uziely, B
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S325 - S325
  • [26] SEQUENTIAL METHOTREXATE, 5-FLUOROURACIL (5-FU), AND HIGH-DOSE LEUCOVORIN VERSUS 5-FU AND HIGH-DOSE LEUCOVORIN VERSUS 5-FU ALONE FOR ADVANCED COLORECTAL-CANCER - A MULTIINSTITUTIONAL RANDOMIZED TRIAL
    ABAD, A
    GARCIA, P
    GRAVALOS, C
    TUSQUETS, I
    FONT, A
    PEREZ, G
    CORTESFUNES, H
    FABREGAT, X
    BARNADAS, A
    ROSELL, R
    CANCER, 1995, 75 (06) : 1238 - 1244
  • [27] A pilot trial of 5-FU, leucovorin, and cisplatin with or without Adriamycin in advanced cancer
    Vaughn, DJ
    Meropol, NJ
    Armstead, B
    Haller, DG
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (03): : 241 - 244
  • [28] Oxaliplatin/5-FU chemotherapy without leucovorin in metastatic colorectal cancer.
    Shim, BY
    Cho, HJ
    Yang, JM
    Kim, HJ
    Kim, JK
    Kim, HK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 302S - 302S
  • [29] Oxaliplatin, 5-FU, and leucovorin (FOLFOX) in advanced biliary tract cancer.
    Lee, S.
    Kim, K. H.
    Kim, H. J.
    Kim, S. H.
    Bae, S. B.
    Kim, C. K.
    Lee, N.
    Lee, K. T.
    Park, S. K.
    Park, S. H.
    Won, J.
    Moon, J. H.
    Hong, D. S.
    Park, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] A pharmacokinetic study of 5-FU/leucovorin and alpha-interferon in advanced cancer
    Larsson, PA
    Glimelius, B
    Jeppsson, B
    Jönsson, PE
    Malmberg, M
    Gustavsson, B
    Carlsson, G
    Svedberg, M
    ACTA ONCOLOGICA, 2000, 39 (01) : 59 - 63
12345